<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Anti-diabetic drug,Oral hypoglycemics,Major Drug Groups,Oral hypoglycemics,Major Drug Groups,2005,2006,ACE inhibitor,ATC code A10,Acarbose,Acetohexamide" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Anti-diabetic drug - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Anti-diabetic drug</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <p>An <b>anti-diabetic drug</b> or <b>oral hypoglycemic agent</b> is used to treat <a href="../../../d/i/a/Diabetes_mellitus.html" title="Diabetes mellitus">diabetes mellitus</a>. They usually work by lowering the <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a> levels in the blood. There are different types of anti-diabetic drugs, and their use depends on the nature of the diabetes, age and situation of the person, as well as other factors.</p>
<p><a href="../../../i/n/s/Insulin.html" title="Insulin">Insulin</a>, <a href="../../../e/x/e/Exenatide.html" title="Exenatide">exenatide</a>, and <a href="../../../p/r/a/Pramlintide.html" title="Pramlintide">pramlintide</a> are the only non-oral antidiabetic drugs. Insulin is the mainstay of treatment in Type I diabetes, in which insulin production is impaired. In Type II diabetes, Insulin is used when oral medication has become ineffective. Exenatide and pramlintide are new injectable medications approved in <a href="../../../2/0/0/2005.html" title="2005">2005</a> in the US by the FDA to treat <a href="../../../d/i/a/Diabetes_mellitus_type_2.html" title="Diabetes mellitus type 2">Diabetes mellitus type 2</a>.</p>
<table width="20%" cellpadding="0" cellspacing="0" style="margin:0" align="right" class="toccolours">
<tr>
<th style="background:#ccccff"><b><a href="../../../d/i/a/Diabetes_mellitus.html" title="Diabetes mellitus">Diabetes mellitus</a></b>
<hr /></th>
</tr>
<tr>
<th style="background:#ccccff"><b>Types of Diabetes</b></th>
</tr>
<tr>
<td><a href="../../../d/i/a/Diabetes_mellitus_type_1.html" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a><br />
<a href="../../../d/i/a/Diabetes_mellitus_type_2.html" title="Diabetes mellitus type 2">Diabetes mellitus type 2</a><br />
<a href="../../../g/e/s/Gestational_diabetes.html" title="Gestational diabetes">Gestational diabetes</a>
<p><b>Pre-diabetes:</b><br />
<a href="../../../i/m/p/Impaired_fasting_glycaemia.html" title="Impaired fasting glycaemia">Impaired fasting glycaemia</a><br />
<a href="../../../i/m/p/Impaired_glucose_tolerance.html" title="Impaired glucose tolerance">Impaired glucose tolerance</a></p>
</td>
</tr>
<tr>
<th style="background:#ccccff"><b>Disease Management</b></th>
</tr>
<tr>
<td><a href="../../../d/i/a/Diabetes_management.html" title="Diabetes management">Diabetes management</a>:<br />
•<a href="../../../d/i/a/Diabetic_diet.html" title="Diabetic diet">Diabetic diet</a><br />
•<strong class="selflink">Anti-diabetic drugs</strong><br />
•<a href="../../../c/o/n/Conventional_insulinotherapy.html" title="Conventional insulinotherapy">Conventional&#160;insulinotherapy</a><br />
•<a href="../../../i/n/t/Intensive_insulinotherapy.html" title="Intensive insulinotherapy">Intensive insulinotherapy</a></td>
</tr>
<tr>
<th style="background:#ccccff"><b>Other Concerns</b></th>
</tr>
<tr>
<td><a href="../../../c/a/r/Cardiovascular_disease.html" title="Cardiovascular disease">Cardiovascular disease</a>
<p><a href="../../../d/i/a/Diabetic_coma.html" title="Diabetic coma">Diabetic comas</a>:<br />
•<a href="../../../d/i/a/Diabetic_hypoglycemia.html" title="Diabetic hypoglycemia">Diabetic hypoglycemia</a><br />
•<a href="../../../d/i/a/Diabetic_ketoacidosis.html" title="Diabetic ketoacidosis">Diabetic ketoacidosis</a><br />
•<a href="../../../n/o/n/Nonketotic_hyperosmolar_coma.html" title="Nonketotic hyperosmolar coma">Nonketotic hyperosmolar</a></p>
<p><a href="../../../d/i/a/Diabetic_myonecrosis.html" title="Diabetic myonecrosis">Diabetic myonecrosis</a><br />
<a href="../../../d/i/a/Diabetic_nephropathy.html" title="Diabetic nephropathy">Diabetic nephropathy</a><br />
<a href="../../../d/i/a/Diabetic_neuropathy.html" title="Diabetic neuropathy">Diabetic neuropathy</a><br />
<a href="../../../d/i/a/Diabetic_retinopathy.html" title="Diabetic retinopathy">Diabetic retinopathy</a></p>
<p><a href="../../../d/i/a/Diabetes_mellitus_and_pregnancy.html" title="Diabetes mellitus and pregnancy">Diabetes and pregnancy</a></p>
</td>
</tr>
<tr>
<th style="background:#ccccff"><b>Blood tests</b></th>
</tr>
<tr>
<td><a href="../../../f/r/u/Fructosamine.html" title="Fructosamine">Fructosamine</a><br />
<a href="../../../g/l/u/Glucose_tolerance_test.html" title="Glucose tolerance test">Glucose tolerance test</a><br />
<a href="../../../g/l/y/Glycosylated_hemoglobin.html" title="Glycosylated hemoglobin">Glycosylated hemoglobin</a></td>
</tr>
</table>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Sulfonylureas"><span class="tocnumber">1</span> <span class="toctext">Sulfonylureas</span></a></li>
<li class="toclevel-1"><a href="#Meglitinides"><span class="tocnumber">2</span> <span class="toctext">Meglitinides</span></a></li>
<li class="toclevel-1"><a href="#Biguanides"><span class="tocnumber">3</span> <span class="toctext">Biguanides</span></a></li>
<li class="toclevel-1"><a href="#Thiazolidinediones"><span class="tocnumber">4</span> <span class="toctext">Thiazolidinediones</span></a></li>
<li class="toclevel-1"><a href="#Alpha_glucosidase_inhibitors"><span class="tocnumber">5</span> <span class="toctext">Alpha glucosidase inhibitors</span></a></li>
<li class="toclevel-1"><a href="#Incretin_mimetic"><span class="tocnumber">6</span> <span class="toctext">Incretin mimetic</span></a></li>
<li class="toclevel-1"><a href="#DPP-4_inhibitors"><span class="tocnumber">7</span> <span class="toctext">DPP-4 inhibitors</span></a></li>
<li class="toclevel-1"><a href="#Amylin_analogue"><span class="tocnumber">8</span> <span class="toctext">Amylin analogue</span></a></li>
<li class="toclevel-1"><a href="#Experimental_agents"><span class="tocnumber">9</span> <span class="toctext">Experimental agents</span></a></li>
<li class="toclevel-1"><a href="#Insulin_by_mouth"><span class="tocnumber">10</span> <span class="toctext">Insulin by mouth</span></a></li>
<li class="toclevel-1"><a href="#Herbal_extracts"><span class="tocnumber">11</span> <span class="toctext">Herbal extracts</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">13</span> <span class="toctext">Footnotes</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Sulfonylureas" id="Sulfonylureas"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Sulfonylureas">edit</a>]</span> <span class="mw-headline">Sulfonylureas</span></h2>
<p><a href="../../../s/u/l/Sulfonylurea.html" title="Sulfonylurea">Sulfonylureas</a> were the first widely used oral hypoglycemic medications. They are <i>insulin <a href="../../../s/e/c/Secretagogue.html" title="Secretagogue">secretagogues</a></i>, triggering insulin release by direct action on the K<sub>ATP <sub>channel of the pancreatic <a href="../../../b/e/t/Beta_cell.html" title="Beta cell">beta cells</a>. Eight types of these pills have been marketed in North America, but not all remain available. The "second-generation" drugs are now more commonly used. They are more effective than first-generation drugs and have fewer side effects.</sub></sub></p>
<p><sub>Sulfonylureas bind strongly to <a href="../../../p/l/a/Plasma_protein.html" title="Plasma protein">plasma proteins</a>. Sulfonylureas are only useful in Type II diabetes, as they work by stimulating endogenous release of insulin. They work best with patients over 40 years old, who have had diabetes mellitus for under ten years. They can not be used with type I diabetes, or diabetes of pregnancy. They can be safely used with metformin or -glitazones. The primary side effect is hypoglycemia.</sub></p>
<ul>
<li><sub>First-generation agents</sub>
<ul>
<li><sub><a href="../../../t/o/l/Tolbutamide.html" title="Tolbutamide">tolbutamide</a> (Orinase)</sub></li>
<li><sub><a href="../../../a/c/e/Acetohexamide.html" title="Acetohexamide">acetohexamide</a> (Dymelor)</sub></li>
<li><sub><a href="../../../t/o/l/Tolazamide.html" title="Tolazamide">tolazamide</a> (Tolinase)</sub></li>
<li><sub><a href="../../../c/h/l/Chlorpropamide.html" title="Chlorpropamide">chlorpropamide</a> (Diabinese)</sub></li>
</ul>
</li>
<li><sub>Second-generation agents</sub>
<ul>
<li><sub><a href="../../../g/l/i/Glipizide.html" title="Glipizide">glipizide</a> (Glucotrol)</sub></li>
<li><sub><a href="../../../g/l/y/Glyburide.html" title="Glyburide">glyburide</a> (Diabeta, Micronase, Glynase)</sub></li>
<li><sub><a href="../../../g/l/i/Glimepiride.html" title="Glimepiride">glimepiride</a> (Amaryl)</sub></li>
<li><sub><a href="../../../g/l/i/Gliclazide.html" title="Gliclazide">gliclazide</a> (Diamicron)</sub></li>
</ul>
</li>
</ul>
<p><sub><a name="Meglitinides" id="Meglitinides"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Meglitinides">edit</a>]</span> <span class="mw-headline">Meglitinides</span></sub></h2>
<p><sub><a href="../../../m/e/g/Meglitinide.html" title="Meglitinide">Meglitinides</a> are related to sulfonylureas and are often called "short-acting secretagogues." The amplification of insulin release is shorter and more intense, and they are taken with meals to boost the insulin response to each meal.</sub></p>
<ul>
<li><sub><a href="../../../r/e/p/Repaglinide.html" title="Repaglinide">repaglinide</a> (Prandin) - The max dosage is 16 mg/day. Take this drug 0 to 30 minutes prior before eating a meal. If a meal is skipped, then the medication should also be skipped.</sub></li>
<li><sub><a href="../../../n/a/t/Nateglinide.html" title="Nateglinide">nateglinide</a> (Starlix) - The max dosage is 360 mg/day, usually 120 mg three times a day (TID). It also follows the same recommendations as repaglinide.</sub></li>
</ul>
<p><sub>Adverse reactions include weight gain and hypoglycemia.</sub></p>
<p><sub><a name="Biguanides" id="Biguanides"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Biguanides">edit</a>]</span> <span class="mw-headline">Biguanides</span></sub></h2>
<p><sub><a href="../../../b/i/g/Biguanide.html" title="Biguanide">Biguanides</a> reduce <a href="../../../l/i/v/Liver.html" title="Liver">hepatic</a> glucose output and increase uptake of glucose by the periphery, including skeletal muscle. Although it must be used with caution in patients with impaired liver or <a href="../../../k/i/d/Kidney.html" title="Kidney">kidney</a> function, metformin has become the most commonly used agent for type 2 diabetes in children and teenagers.</sub></p>
<ul>
<li><sub><a href="../../../m/e/t/Metformin.html" title="Metformin">metformin</a> (Glucophage)</sub></li>
<li><sub>Phenformin (DBI): used in 1960-1980s, withdrawn due to lactic acidosis risk.</sub></li>
</ul>
<p><sub>Metformin should be temporarily discontinued before any radiographic procedure involving intravenous iodinated contrast as patients are at an increased risk of lactic acidosis.</sub></p>
<p><sub><a name="Thiazolidinediones" id="Thiazolidinediones"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Thiazolidinediones">edit</a>]</span> <span class="mw-headline">Thiazolidinediones</span></sub></h2>
<p><sub><a href="../../../t/h/i/Thiazolidinedione.html" title="Thiazolidinedione">Thiazolidinediones</a>, also known as "glitazones," bind to <a href="../../../p/e/r/Peroxisome_proliferator-activated_receptor.html" title="Peroxisome proliferator-activated receptor">PPARγ</a>, a type of nuclear regulatory protein involved in transcription of numerous genes regulating glucose and fat metabolism. They act as "insulin sensitizers" without increasing insulin secretion.</sub></p>
<ul>
<li><sub><a href="../../../r/o/s/Rosiglitazone.html" title="Rosiglitazone">rosiglitazone</a> (Avandia)</sub></li>
<li><sub><a href="../../../p/i/o/Pioglitazone.html" title="Pioglitazone">pioglitazone</a> (Actos)</sub></li>
<li><sub><a href="../../../t/r/o/Troglitazone.html" title="Troglitazone">troglitazone</a> (Rezulin): used in 1990s, withdrawn due to <a href="../../../h/e/p/Hepatitis.html" title="Hepatitis">hepatitis</a> and liver damage risk.</sub></li>
</ul>
<p><sub><a name="Alpha_glucosidase_inhibitors" id="Alpha_glucosidase_inhibitors"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Alpha glucosidase inhibitors">edit</a>]</span> <span class="mw-headline">Alpha glucosidase inhibitors</span></sub></h2>
<p><sub><a href="../../../a/l/p/Alpha_glucosidase_inhibitor.html" title="Alpha glucosidase inhibitor">Alpha glucosidase inhibitors</a> are "diabetes pills" but not technically hypoglycemic agents because they do not have a direct effect on insulin secretion or sensitivity. These agents slow the digestion of starch in the small intestine, so that glucose from the starch of a meal enters the bloodstream more slowly, and can be matched more effectively by an impaired insulin response or sensitivity. These agents are effective by themselves only in the earliest stages of <a href="../../../i/m/p/Impaired_glucose_tolerance.html" title="Impaired glucose tolerance">impaired glucose tolerance</a>, but can be helpful in combination with other agents in <a href="../../../t/y/p/Type_2_diabetes.html" title="Type 2 diabetes">type 2 diabetes</a>.</sub></p>
<ul>
<li><sub><a href="../../../m/i/g/Miglitol.html" title="Miglitol">miglitol</a> (Glyset)</sub></li>
<li><sub><a href="../../../a/c/a/Acarbose.html" title="Acarbose">acarbose</a> (Precose/Glucobay)</sub></li>
</ul>
<p><sub>These medications are rarely used in the United States because of the severity of their side effects (flatulence and bloating). They are more commonly prescribed in Europe.</sub></p>
<p><sub><a name="Incretin_mimetic" id="Incretin_mimetic"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Incretin mimetic">edit</a>]</span> <span class="mw-headline">Incretin mimetic</span></sub></h2>
<p><sub><b><a href="../../../e/x/e/Exenatide.html" title="Exenatide">Exenatide</a></b> (also Exendin-4, marketed as Byetta) is the first of a new class of medications approved for the treatment of <a href="../../../t/y/p/Type_2_diabetes.html" title="Type 2 diabetes">type 2 diabetes</a>. It is to be used in conjunction with oral medications such as <a href="../../../m/e/t/Metformin.html" title="Metformin">metformin</a> and/or a <a href="../../../s/u/l/Sulfonylurea.html" title="Sulfonylurea">sulfonylurea</a> to improve glucose control. The medication is injected twice per day using a specially designed pen. The typical human response is both an improvement of the release of internal insulin by the pancreas and suppression of pancreas glucagon release, behaviors more typical of individuals without blood sugar control problems. In the presence of exenatide, these responses are greater when the blood sugar is elevated.</sub></p>
<p><sub><a name="DPP-4_inhibitors" id="DPP-4_inhibitors"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: DPP-4 inhibitors">edit</a>]</span> <span class="mw-headline">DPP-4 inhibitors</span></sub></h2>
<ul>
<li><sub><a href="../../../d/i/p/Dipeptidyl_peptidase-4_inhibitors.html" title="Dipeptidyl peptidase-4 inhibitors">Dipeptidyl peptidase-4 (DPP-4) inhibitors</a> (<a href="../../../v/i/l/Vildagliptin.html" title="Vildagliptin">vildagliptin</a>, <a href="../../../s/i/t/Sitagliptin.html" title="Sitagliptin">sitagliptin</a>) increase blood concentration of GLP-1 (<a href="../../../g/l/u/Glucagon-like_peptide-1.html" title="Glucagon-like peptide-1">glucagon-like peptide-1</a>).</sub></li>
</ul>
<p><sub><a name="Amylin_analogue" id="Amylin_analogue"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Amylin analogue">edit</a>]</span> <span class="mw-headline">Amylin analogue</span></sub></h2>
<ul>
<li><sub><a href="../../../p/r/a/Pramlintide.html" title="Pramlintide">Pramlintide</a>.</sub></li>
</ul>
<p><sub><a name="Experimental_agents" id="Experimental_agents"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Experimental agents">edit</a>]</span> <span class="mw-headline">Experimental agents</span></sub></h2>
<p><sub>Many other potential drugs are currently in investigation by pharmaceutical companies. Some of these are simply newer members of one of the above classes, but some work by novel mechanisms. For example, at least one compound that enhances the sensitivity of <a href="../../../g/l/u/Glucokinase.html" title="Glucokinase">glucokinase</a> to rising glucose is in the stage of animal research. Others are undergoing phase I/II studies.</sub></p>
<ul>
<li><sub>PPARα/γ ligands (muraglitazar and tesaglitazar) - development stopped due to adverse risk profile</sub></li>
<li><sub>SGLT (sodium-dependent glucose transporter 1) inhibitors increase urinary glucose.</sub></li>
<li><sub>FBPase (fructose 1,6-bisphosphatase) inhibitors decrease gluconeogenesis in liver.</sub></li>
</ul>
<p><sub><a name="Insulin_by_mouth" id="Insulin_by_mouth"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Insulin by mouth">edit</a>]</span> <span class="mw-headline">Insulin by mouth</span></sub></h2>
<p><sub>The basic appeal of oral hypoglycemic agents is that most people would prefer a pill to an injection. Unlike all the oral drugs described in this article, insulin is a <a href="../../../p/r/o/Protein.html" title="Protein">protein</a>. Protein hormones, like meat proteins, are <a href="../../../d/i/g/Digestion.html" title="Digestion">digested</a> in the <a href="../../../s/t/o/Stomach.html" title="Stomach">stomach</a> and <a href="../../../g/u/t/Gut.html" title="Gut">gut</a>. One alternative delivery method is by inhalation. In <a href="../../../2/0/0/2006.html" title="2006">2006</a> the U.S. <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> approved the use of <a href="../../../e/x/u/Exubera.html" title="Exubera">Exubera</a>, the first inhalable insulin.</sub></p>
<p><sub>However, the potential market for an oral form of insulin is enormous and many laboratories have attempted to devise ways of moving enough intact insulin from the gut to the <a href="../../../p/o/r/Portal_vein.html" title="Portal vein">portal vein</a> to have a measurable effect on blood sugar. One can find several research reports over the years describing promising approaches or limited success in animals, and limited human testing, but as of 2004, no products appear to be successful enough to bring to market.<a href="http://www.ias.ac.in/resonance/May2003/May2003p38-46.html" class="external autonumber" title="http://www.ias.ac.in/resonance/May2003/May2003p38-46.html" rel="nofollow">[1]</a></sub></p>
<p><sub><a name="Herbal_extracts" id="Herbal_extracts"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Herbal extracts">edit</a>]</span> <span class="mw-headline">Herbal extracts</span></sub></h2>
<p><sub>The first registred use of <i>anti-diabetic drugs</i> was as <i>herbal extracts</i> used by Indians in the <a href="../../../a/m/a/Amazon_Basin_4563.html" title="Amazon Basin">Amazon Basin</a> for the treatment of <i>type 2 diabetes</i>, and today promoted as <i>vegetable insulin</i> although not formally an <a href="../../../i/n/s/Insulin_analog.html" title="Insulin analog">insulin analog</a>.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup> The major recent development was done in <a href="../../../b/r/a/Brazil.html" title="Brazil">Brazil</a> around <a href="../../../m/y/r/Myrcia_sphaerocarpa.html" title="Myrcia sphaerocarpa">Myrcia sphaerocarpa</a> and other <a href="../../../m/y/r/Myrcia.html" title="Myrcia">Myrcia</a> species.</sub></p>
<blockquote>
<p><sub>"Many countries, especially in the developing world, have a long history of the use of herbal remedies in diabetes (...) STZ diabetic rats were also used to test <i>Myrcia Uniflora</i> extracts (...) ".<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup></sub></p>
</blockquote>
<p><sub>The usual treatment is with concentrated (root) <i>Myrcia</i> extracts, commercialized in a 4 US dollar per kilogram packed rocks (~100 times cheaper than equivalent artificial drugs), named "Pedra hume de kaá". Phytochemical analysis of the <i>Myrcia</i> extracts reported kinds of flavanone glucosides (myrciacitrins) and acetophenone glucosides (myrciaphenones), and inhibitory activities on aldose reductase and alpha-glucosidase.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup></sub></p>
<p><sub>A recent review article presents the profiles of plants with hypoglycaemic properties, reported in the literature from 1990 to 2000 and states that <i>"Medical plants play an important role in the management of diabetes mellitus especially in developing countries where resources are meager."</i><sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup></sub></p>
<p><sub><a name="References" id="References"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></sub></h2>
<ul>
<li><sub>Lebovitz HE. <b>Therapy for Diabetes Mellitus and Related Disorders</b>. 4th edition. Alexandria: American Diabetes Association, 2004.</sub></li>
<li><sub>Holland, Norman &amp; Adams, Michael Patrick. <b>Core Concepts in Pharmacology</b>. Pearson Education, Inc. New Jersey. 2003.</sub></li>
</ul>
<p><sub><a name="Footnotes" id="Footnotes"></a></sub></p>
<h2><sub><span class="editsection">[<a href="../../../a/n/t/Anti-diabetic_drug.html" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></sub></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><sub><b><a href="#_ref-0" title="">^</a></b> <cite class="book" style="font-style:normal">Soumyanath, Amala(ed.) (2005-11-01). <i>Traditional Medicines for Modern Times</i>, 1st Edition (in english), Taylor &amp; Francis. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-415-33464-0</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Traditional+Medicines+for+Modern+Times&amp;rft.title=Traditional+Medicines+for+Modern+Times&amp;rft.aulast=Soumyanath&amp;rft.aufirst=Amala%28ed.%29&amp;rft.date=2005-11-01&amp;rft.edition=1st+Edition&amp;rft.pub=Taylor+%26+Francis">&#160;</span></sub></li>
<li id="_note-1"><sub><b><a href="#_ref-1" title="">^</a></b> <cite class="book" style="font-style:normal">McNeill, John H. (1999-02-01). <i>Experimental Models of Diabetes</i>, 1st Edition (in english), CRC Press, 208. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-8493-1667-7</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Experimental+Models+of+Diabetes&amp;rft.title=Experimental+Models+of+Diabetes&amp;rft.aulast=McNeill&amp;rft.aufirst=John+H.&amp;rft.date=1999-02-01&amp;rft.edition=1st+Edition&amp;rft.pub=CRC+Press&amp;rft.pages=208">&#160;</span></sub></li>
<li id="_note-2"><sub><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Matsuda, H; Nishida N, Yoshikawa M. (Mar 2002). "Antidiabetic principles of natural medicines. V. Aldose reductase inhibitors from Myrcia multiflora DC. (2): Structures of myrciacitrins III, IV, and V.". <i>Chem Pharm Bull (Tokyo)</i> <b>50(3)</b>: 429-31.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Antidiabetic+principles+of+natural+medicines.+V.+Aldose+reductase+inhibitors+from+Myrcia+multiflora+DC.+%282%29%3A+Structures+of+myrciacitrins+III%2C+IV%2C+and+V.&amp;rft.title=Chem+Pharm+Bull+%28Tokyo%29&amp;rft.jtitle=Chem+Pharm+Bull+%28Tokyo%29&amp;rft.date=2002&amp;rft.volume=50%283%29&amp;rft.aulast=Matsuda&amp;rft.aufirst=H&amp;rft.pages=429-31">&#160;</span></sub></li>
<li id="_note-3"><sub><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Bnouham M et al (2006). "<a href="http://ijod.uaeu.ac.ae/iss_1401/a.pdf" class="external text" title="http://ijod.uaeu.ac.ae/iss_1401/a.pdf" rel="nofollow">Medicinal plants with potential antidiabetic activity - A review of ten years of herbal medicine research (1990-2000)</a>". <i>Int J Diabetes &amp; Metabolism</i> <b>14</b>: 1-25.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Medicinal+plants+with+potential+antidiabetic+activity+-+A+review+of+ten+years+of+herbal+medicine+research+%281990-2000%29&amp;rft.title=Int+J+Diabetes+%26+Metabolism&amp;rft.jtitle=Int+J+Diabetes+%26+Metabolism&amp;rft.date=2006&amp;rft.volume=14&amp;rft.au=Bnouham+M+et+al&amp;rft.pages=1-25&amp;rft_id=http%3A%2F%2Fijod.uaeu.ac.ae%2Fiss_1401%2Fa.pdf">&#160;</span></sub></li>
</ol>
</div>
<table class="navbox collapsible" style="margin:auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../o/r/a/Template%7EOral_hypoglycemics_2f97.html" title="Template:Oral hypoglycemics"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../o/r/a/Template_talk%7EOral_hypoglycemics_3fef.html" title="Template talk:Oral hypoglycemics"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../o/r/a/Template%7EOral_hypoglycemics_2f97.html" class="external text" title="http://en.wikipedia.org../../../o/r/a/Template%7EOral_hypoglycemics_2f97.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="../../../o/r/a/Oral_hypoglycemics.html" title="Oral hypoglycemics">Oral antidiabetic drugs</a> (<a href="../../../a/t/c/ATC_code_A10_5bd5.html#A10B_Oral_blood_glucose_lowering_drugs" title="ATC code A10">A10B</a>)</span></th>
</tr>
<tr>
<th style=""><a href="../../../b/i/g/Biguanide.html" title="Biguanide">Biguanides</a></th>
<td style="" colspan="1"><a href="../../../m/e/t/Metformin.html" title="Metformin">Metformin</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/u/l/Sulfonylurea.html" title="Sulfonylurea">Sulfonylureas</a></th>
<td style="" colspan="1"><a href="../../../c/h/l/Chlorpropamide.html" title="Chlorpropamide">Chlorpropamide</a>, <a href="../../../g/l/i/Glibenclamide.html" title="Glibenclamide">glibenclamide (Glyburide)</a>, <a href="../../../g/l/i/Gliclazide.html" title="Gliclazide">Gliclazide</a>, <a href="../../../g/l/i/Glimepiride.html" title="Glimepiride">Glimepiride</a>, <a href="../../../g/l/i/Glipizide.html" title="Glipizide">Glipizide</a>, <a href="../../../g/l/i/Gliquidone.html" title="Gliquidone">Gliquidone</a>, <a href="../../../t/o/l/Tolazamide.html" title="Tolazamide">Tolazamide</a>, <a href="../../../t/o/l/Tolbutamide.html" title="Tolbutamide">Tolbutamide</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/p/Alpha-glucosidase_inhibitor.html" title="Alpha-glucosidase inhibitor">Alpha-glucosidase inhibitors</a></th>
<td style="" colspan="1"><a href="../../../a/c/a/Acarbose.html" title="Acarbose">Acarbose</a>, <a href="../../../m/i/g/Miglitol.html" title="Miglitol">Miglitol</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/h/i/Thiazolidinedione.html" title="Thiazolidinedione">Thiazolidinediones (TZD)</a></th>
<td style="" colspan="1"><a href="../../../p/i/o/Pioglitazone.html" title="Pioglitazone">Pioglitazone</a>, <a href="../../../r/o/s/Rosiglitazone.html" title="Rosiglitazone">Rosiglitazone</a>, <a href="../../../t/r/o/Troglitazone.html" title="Troglitazone">Troglitazone</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/e/g/Meglitinide.html" title="Meglitinide">Meglitinides</a></th>
<td style="" colspan="1"><a href="../../../n/a/t/Nateglinide.html" title="Nateglinide">Nateglinide</a>, <a href="../../../r/e/p/Repaglinide.html" title="Repaglinide">Repaglinide</a>, <a href="../../../m/i/t/Mitiglinide.html" title="Mitiglinide">Mitiglinide</a></td>
</tr>
<tr>
<th style=""><a href="../../../d/i/p/Dipeptidyl_peptidase-4_inhibitors.html" title="Dipeptidyl peptidase-4 inhibitors">Dipeptidyl peptidase-4 (DPP-4) inhibitors</a></th>
<td style="" colspan="1"><a href="../../../s/a/x/Saxagliptin.html" title="Saxagliptin">Saxagliptin</a>, <a href="../../../s/i/t/Sitagliptin.html" title="Sitagliptin">Sitagliptin</a>, <a href="../../../v/i/l/Vildagliptin.html" title="Vildagliptin">Vildagliptin</a></td>
</tr>
</table>
<table class="navbox collapsible autocollapse" style="margin:auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" title="Template:Major Drug Groups"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../m/a/j/Template_talk%7EMajor_Drug_Groups_149b.html" title="Template talk:Major Drug Groups"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" class="external text" title="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;">Major Drug Groups</span></th>
</tr>
<tr>
<th style=""><a href="../../../b/r/a/Brain.html" title="Brain">Brain</a> and <a href="../../../n/e/r/Nervous_system.html" title="Nervous system">Nervous system</a></th>
<td style="" colspan="1"><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a>, <a href="../../../a/n/e/Anesthesia.html" title="Anesthesia">Anesthetics</a>, <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">Anxiolytics</a>, <a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">Antidepressants</a>, <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">Antipsychotics</a>, <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">Anticonvulsants</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">Nervous system stimulants</a>, <a href="../../../a/n/t/Antiemetic.html" title="Antiemetic">Antiemetics</a>, <a href="../../../p/s/y/Psychedelics%2C_dissociatives_and_deliriants.html" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a>, <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">Mood stabilizers</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">Respiratory system</a></th>
<td style="" colspan="1"><a href="../../../b/r/o/Bronchodilator.html" title="Bronchodilator">Bronchodilators</a>, <a href="../../../d/e/c/Decongestant.html" title="Decongestant">Decongestants</a></td>
</tr>
<tr>
<th style=""><a href="../../../h/e/a/Heart.html" title="Heart">Heart</a> and <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">Circulation</a></th>
<td style="" colspan="1"><a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">Angiotensin converting enzyme inhibitors</a>, <a href="../../../a/n/t/Antiarrhythmic_agent.html" title="Antiarrhythmic agent">Antiarrhythmics</a>, <a href="../../../a/n/t/Antianginal.html" title="Antianginal">Antianginals</a>, <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">Antihypertensives</a>, <a href="../../../h/y/p/Hypolipidemic_agent.html" title="Hypolipidemic agent">Antihyperlipidemics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">Anticoagulants</a>, <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">Antiplatelets</a>, <a href="../../../b/e/t/Beta_blocker.html" title="Beta blocker">Beta blockers</a>, <a href="../../../d/i/u/Diuretic.html" title="Diuretic">Diuretics</a>, <a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">Thrombolytics</a>, <a href="../../../v/a/s/Vasodilator.html" title="Vasodilator">Vasodilators</a></td>
</tr>
<tr>
<th style=""><a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">Gastrointestinal tract</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antacid.html" title="Antacid">Antacids</a>, <a href="../../../a/n/t/Antidiarrhoeal.html" title="Antidiarrhoeal">Antidiarrhoeals</a>, <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonists</a>, <a href="../../../p/r/o/Proton_pump_inhibitor.html" title="Proton pump inhibitor">Proton pump inhibitors</a>, <a href="../../../l/a/x/Laxative.html" title="Laxative">Laxatives</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/u/s/Muscle.html" title="Muscle">Muscles</a>, <a href="../../../b/o/n/Bone.html" title="Bone">Bones</a>, and <a href="../../../j/o/i/Joint.html" title="Joint">Joints</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Anti-inflammatory.html" title="Anti-inflammatory">Anti-inflammatories</a>, <a href="../../../d/i/s/Disease-modifying_antirheumatic_drug.html" title="Disease-modifying antirheumatic drug">Antirheumatics</a>, <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../m/u/s/Muscle_relaxant.html" title="Muscle relaxant">Muscle relaxants</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/l/Allergy.html" title="Allergy">Allergy</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">Antihistamines</a></td>
</tr>
<tr>
<th style=""><a href="../../../i/n/f/Infection.html" title="Infection">Infections</a> and <a href="../../../i/n/f/Infestation.html" title="Infestation">Infestations</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">Antibiotics</a>, <a href="../../../a/n/t/Antiviral_drug.html" title="Antiviral drug">Antivirals</a>, <a href="../../../v/a/c/Vaccine.html" title="Vaccine">Vaccines</a>, <a href="../../../a/n/t/Antiprotozoal_agent.html" title="Antiprotozoal agent">Antiprotozoals</a>, <a href="../../../a/n/t/Antifungal_drug.html" title="Antifungal drug">Antifungals</a>, <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">Anthelmintics</a></td>
</tr>
<tr>
<th style=""><a href="../../../e/n/d/Endocrine_system.html" title="Endocrine system">Endocrine system</a></th>
<td style="" colspan="1"><a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <strong class="selflink">Anti-diabetics</strong></td>
</tr>
<tr>
<th style=""><a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a> and <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune</a> disease</th>
<td style="" colspan="1"><a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Anticancer agents</a>, <a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressants</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/p/Reproductive_system.html" title="Reproductive system">Reproductive system</a></th>
<td style="" colspan="1"><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraception</a>, <a href="../../../f/e/r/Fertility_medication.html" title="Fertility medication">Fertility agents</a>, <a href="../../../s/e/l/Selective_estrogen_receptor_modulator.html" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/k/i/Skin.html" title="Skin">Skin</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antipruritic.html" title="Antipruritic">Antipruritics</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 46347 bytes
Post-expand include size: 25077 bytes
Template argument size: 12413 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Anti-diabetic_drug.html">http://en.wikipedia.org../../../a/n/t/Anti-diabetic_drug.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../d/i/a/Category%7EDiabetes_26a5.html" title="Category:Diabetes">Diabetes</a></span> | <span dir='ltr'><a href="../../../a/n/t/Category%7EAnti-diabetic_drugs_c760.html" title="Category:Anti-diabetic drugs">Anti-diabetic drugs</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Anti-diabetic_drug.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAnti-diabetic_drug_fe9b.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Anti-diabetic_drug">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../ar/%D9%85/%D8%B6/%D8%A7/%D9%85%D8%B6%D8%A7%D8%AF%D8%A7%D8%AA_%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A.html">العربية</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/n/t/Antidiabetikum.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/n/t/Antidiab%C3%A9tique.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E7%B5%8C/%E5%8F%A3/%E8%A1%80/%E7%B5%8C%E5%8F%A3%E8%A1%80%E7%B3%96%E9%99%8D%E4%B8%8B%E8%96%AC.html">日本語</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 18:44, 1 April 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../g/a/i/User%7EGaius_Cornelius_c35a.html" title="User:Gaius Cornelius">Gaius Cornelius</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../b/e/n/User%7EBenjaminevans82_7c6f.html" title="User:Benjaminevans82">Benjaminevans82</a>, <a href="../../../j/o/e/User%7EJoeSmack_29f9.html" title="User:JoeSmack">JoeSmack</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../c/y/b/User%7ECybergoth_b23c.html" title="User:Cybergoth">Cybergoth</a>, Mistered24, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../k/r/a/User%7EKrauss_51ee.html" title="User:Krauss">Krauss</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../e/p/o/User%7EEpolk_d8a6.html" title="User:Epolk">Epolk</a>, <a href="../../../n/e/p/User%7ENephron_555e.html" title="User:Nephron">Nephron</a>, <a href="../../../h/d/o/User%7EHDow_8957.html" title="User:HDow">HDow</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../m/o/h/User%7EMohammed_Khalil_ade5.html" title="User:Mohammed Khalil">Mohammed Khalil</a>, <a href="../../../c/o/l/User%7EColin_66ca.html" title="User:Colin">Colin</a>, <a href="../../../r/i/c/User%7ERich_Farmbrough_7642.html" title="User:Rich Farmbrough">Rich Farmbrough</a>, <a href="../../../s/t/u/User%7EStuartr_fd01.html" title="User:Stuartr">Stuartr</a>, <a href="../../../a/u/s/User%7EAuslander99_ecdc.html" title="User:Auslander99">Auslander99</a>, Jlui21, <a href="../../../r/o/y/User%7ERoyBoy_492a.html" title="User:RoyBoy">RoyBoy</a>, <a href="../../../k/n/o/User%7EKnowledge_Seeker_08dc.html" title="User:Knowledge Seeker">Knowledge Seeker</a>, <a href="../../../j/o/y/User%7EJoyous%21_8a6f.html" title="User:Joyous!">Joyous!</a>, <a href="../../../r/e/v/User%7ERevived_da18.html" title="User:Revived">Revived</a>, <a href="../../../j/h/5/User%7EJh51681_85eb.html" title="User:Jh51681">Jh51681</a>, <a href="../../../e/v/e/User%7EEveryking_5c9e.html" title="User:Everyking">Everyking</a>, <a href="../../../k/i/n/User%7EKingTT_2975.html" title="User:KingTT">KingTT</a>, <a href="../../../e/r/a/User%7EEras-mus_f9f9.html" title="User:Eras-mus">Eras-mus</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../c/e/n/User%7ECentrx_80e4.html" title="User:Centrx">Centrx</a>, <a href="../../../w/i/k/User%7EWikiborg_3c13.html" title="User:Wikiborg">Wikiborg</a> and <a href="../../../t/r/i/User%7ETristanb_d761.html" title="User:Tristanb">Tristanb</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
